FDA Philippines

The Food and Drug Administration Philippines (FDA PH — Pangasiwaan sa Pagkain at Gamot) is the Philippines' national regulator for human and veterinary medicines, biologicals, vaccines, medical devices, IVDs, cosmetics, household urban hazardous substances, tobacco and processed food. FDA PH was reorganised under Republic Act 9711 (Food and Drug Administration Act of 2009) from the former Bureau of Food and Drugs (BFAD) and operates from Muntinlupa under the Department of Health (DOH), with regional field offices across the country.

The Philippines participates in ASEAN medicines and medical-device harmonisation. Medicines are registered under the ASEAN Common Technical Dossier (ACTD) format for generics with ICH CTD accepted for innovator products; medical devices follow the ASEAN Medical Device Directive (AMDD) with a four-class (A/B/C/D) risk-classified pathway aligned to IMDRF principles. FDA PH operates reliance pathways for reference-authority approvals (FDA US, EMA, MHRA, Health Canada, TGA, Swissmedic, PMDA) that shorten review timelines. Cosmetics follow the ASEAN Cosmetic Directive with post-marketing notification rather than pre-market registration.

GMP inspections of overseas manufacturers are risk-based; PIC/S / EU / FDA GMP certificates support desk review, while biologicals, sterile products, vaccines and high-risk devices attract on-site inspection. FDA PH is a PIC/S applicant and works closely with WHO Prequalification. V5 Ultimate maps directly onto FDA PH expectations — bound e-signatures, ALCOA+ batch records, deviation/CAPA workflow, and a per-country dossier pack — with the paired guide at /glossary/philippines-fda.